Silver Book Fact

A statin initiation intervention aimed at Medicare Part D prescription drug plan subscribers with diabetes or coronary artery disease was successful in increasing statin use among this group of members at high risk for cardiovascular events. The estimated coronary event cost avoidance was $12,323 per 220 members who received the intervention.

Stockl, Karen M., Daniel Tjioe, Sherry Gong, Jenni Stroup, Ann S.M. Harada, and Heidi C. Lew. Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program. J Manag Care Pharm. 2008; 14(6): 532-40. http://www.amcp.org/data/jmcp/JMCPMaga_532-540.pdf

Reference

Title
Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program
Publication
J Manag Care Pharm
Publication Date
2008
Authors
Stockl, Karen M., Daniel Tjioe, Sherry Gong, Jenni Stroup, Ann S.M. Harada, and Heidi C. Lew
Volume & Issue
Volume 14, Issue 6
Pages
532-40
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • During the first year of a community pharmacy services program in 2003 which included 256 diabetes patients who used scheduled consultations, clinical goal setting, monitoring, and collaborative drug therapy management…  
  • DR Treatment Reduced Risk of Blindness
    Appropriate treatment can reduce the risk of blindness or moderate vision loss from DR by more than 90%.  
  • Evaluation of a Cooperative Extension Service diabetes education program showed improved nutrition knowledge, anthropometric measures and glucose control. These improvements reduced medical costs by approximately $94,010 for the 62 participants.  
  • Average direct medical costs over time, in 2001, for 194 participants in a community-based pharmaceutical care services program for patients with diabetes.  
  • A study by the Diabetes Prevention Program found that the use of the drug metformin by high-risk patients reduced the risk of development of type 2 diabetes by 31%.